MedPath

Phase I study of S-1 plus cisplatin and intraperitoneal administration of paclitaxel for gastric cacner with peritoneal metastasis

Phase 1
Conditions
gastric cancer with peritoneal metastasis
Registration Number
JPRN-UMIN000013528
Lead Sponsor
agoya University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
9
Inclusion Criteria

Not provided

Exclusion Criteria

Other active concomitant malignancies, massive ascites or other severe medical conditions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
safety
Secondary Outcome Measures
NameTimeMethod
negative conversion rate on peritoneal cytology
© Copyright 2025. All Rights Reserved by MedPath